论文部分内容阅读
乙型肝炎通常是一种自限性疾病,但在社会团体中还是一个重要发病原因。一旦这种病已确定,没有一种已知的治疗方法能改变其病程。医疗处置上仍是被动的。转移因子(TF)在治疗某些病毒性感染中有理论上的价值。乙型肝炎患者常常显示细胞介导免疫应答减低,TF治疗可能改善这种情况。一些报告表明,乙型肝炎患者用TF治疗显示临床改善。在奥克兰的初步无对照试验证实了这个观察。本文报导对29例乙型肝炎患者进行一项前瞻性双盲对照试验,13例接受TF,16
Hepatitis B is usually a self-limiting disease, but it is still an important cause of illness in social groups. Once the disease has been established, no known method of treatment can change its course. Medical treatment is still passive. Transfer factor (TF) is of theoretical value in the treatment of certain viral infections. Hepatitis B patients often show a decrease in the cell-mediated immune response and TF treatment may improve this condition. Some reports indicate that treatment with TF in patients with hepatitis B shows clinical improvement. The first uncontrolled trial in Auckland confirmed this observation. This article reports a prospective, double-blind, controlled trial of 29 patients with hepatitis B and 13 patients with TF, 16